Uni-Bio Science Group Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	179.89	65.01	129.24	98.22	83.61
Short-Term Investments	18.86	119.87	12.36	10.4	6.72
Cash & Short-Term Investments	198.76	184.87	141.59	108.62	90.33
Cash Growth	7.51%	30.57%	30.35%	20.26%	17.82%
Accounts Receivable	90.43	70.24	53.22	57.87	71.63
Other Receivables	-0.55	-0.79	0.59	-	-
Receivables	98.58	100.13	60.11	57.87	71.63
Inventory	37	33.78	36.39	33.85	39.71
Total Current Assets	334.34	318.78	238.1	200.34	201.67
Property, Plant & Equipment	178.08	138.34	104.08	59.87	57.45
Long-Term Investments	1.58	-	-	-	-
Other Intangible Assets	1.91	2.24	2.67	3.09	3.81
Long-Term Deferred Tax Assets	2.58	4.12	3.85	0.43	-
Long-Term Deferred Charges	36.29	34.22	36.59	21.03	4.37
Other Long-Term Assets	12.92	19.44	15.47	7.71	0.3
Total Assets	579.8	517.55	409.99	292.47	267.59
Accounts Payable	21.17	15.23	9.31	5.27	5.26
Accrued Expenses	12.03	22.8	38.8	27.96	43.21
Short-Term Debt	5.22	5.26	8.86	0.13	-
Current Portion of Long-Term Debt	32.33	43.31	11.04	11.19	-
Current Portion of Leases	5.92	6.18	4.23	4.01	4.61
Current Income Taxes Payable	0.87	2.41	2.18	3.11	1.72
Current Unearned Revenue	18.29	17.67	25.16	21.81	20.21
Other Current Liabilities	7.73	10.64	15.22	16.78	17.29
Total Current Liabilities	103.55	123.5	114.79	90.26	92.3
Long-Term Debt	55.51	56.01	30.61	-	-
Long-Term Leases	3.99	9.7	6.99	7.47	0.99
Long-Term Unearned Revenue	1.97	0.26	-	-	-
Long-Term Deferred Tax Liabilities	1.53	2.45	0.43	-	-
Total Liabilities	166.56	191.91	152.82	97.73	93.29
Common Stock	59.71	59.71	63.65	63.65	63.5
Additional Paid-In Capital	709.15	725.69	751.76	751.76	750.77
Retained Earnings	-437.21	-544.52	-628.48	-699.36	-737.87
Treasury Stock	-	-	-5.17	-	-
Comprehensive Income & Other	81.59	84.76	75.42	78.7	97.91
Shareholders' Equity	413.25	325.65	257.17	194.75	174.31
Total Liabilities & Equity	579.8	517.55	409.99	292.47	267.59
Total Debt	102.97	120.45	61.73	22.8	5.6
Net Cash (Debt)	95.78	64.42	79.87	85.82	84.73
Net Cash Growth	48.68%	-19.33%	-6.94%	1.29%	15.23%
Net Cash Per Share	0.02	0.01	0.01	0.01	0.01
Filing Date Shares Outstanding	5,971	5,971	6,279	6,365	6,350
Total Common Shares Outstanding	5,971	5,971	6,279	6,365	6,350
Working Capital	230.79	195.28	123.31	110.09	109.36
Book Value Per Share	0.07	0.05	0.04	0.03	0.03
Tangible Book Value	411.34	323.41	254.51	191.66	170.5
Tangible Book Value Per Share	0.07	0.05	0.04	0.03	0.03
Buildings	96.67	86.67	87.95	88.88	90.45
Machinery	187.2	160.98	118.54	117.24	127.38
Construction In Progress	63.62	41.11	54.56	5.81	2.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.